CFA
CYTR

Camarda Financial Advisors’s CytRx Corp CYTR Stock Holding History

Camarda Financial Advisors’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-126
Closed -$2K – 278
2016
Q2 		$2K Buy
+126
New +$2.1K ﹤0.01% 247

Other funds holding CYTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Camarda Financial Advisors's CYTR Position: Q3 2016 in Review

Camarda Financial Advisors sold out of CytRx Corp (CYTR) in Q3 2016, closing a stake of 126 shares — an estimated $2K sold.

Camarda Financial Advisors first reported a position in CYTR in Q2 2016 and held it in 1 quarter. The position peaked at $2K in Q2 2016. 72 funds tracked by Wall St. Rank hold CYTR as of Q3 2016.

  • Camarda Financial Advisors reported no remaining CytRx Corp position as of Q3 2016 after selling out during the quarter.
  • Camarda Financial Advisors sold 126 CytRx Corp shares in Q3 2016, an estimated $2K.
  • Camarda Financial Advisors first reported a position in CytRx Corp in Q2 2016 and held it in 1 quarter.
  • Camarda Financial Advisors's CytRx Corp position peaked at $2K in Q2 2016.
  • 72 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2016.

Based on Camarda Financial Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.